Ketamine Clinics in Jersey City, NJ
1 provider found in Jersey City, New Jersey
Showing 1 clinic in Jersey City
35 Journal Square Plaza, Jersey City, NJ 07306
Jersey City is New Jersey's most clinic-dense market for ketamine therapy, with providers serving patients from Hudson County and the surrounding area. Situated directly across the Hudson River from Lower Manhattan, Jersey City attracts patients who prefer to avoid Manhattan traffic and high costs while still accessing an experienced provider market. PATH train and ferry connections make Jersey City among the most transit-accessible ketamine therapy markets outside of Manhattan itself.
Local Clinical Landscape
Jersey City's ketamine providers serve patients from across Hudson County and the broader NYC metro area. The city's proximity to Manhattan means some patients alternate between Jersey City and New York City providers depending on scheduling and availability. Jersey City providers offer a practical alternative to Manhattan clinics, typically with easier logistics — including accessible parking — and similar clinical quality. IV infusion is the primary modality available in Jersey City, with Spravato and IM options at select providers.
Cost & Pricing
Jersey City ketamine clinics typically charge in line with the broader New Jersey market, with IV infusions ranging from $400–$500 per session. Northern New Jersey pricing reflects the NYC metro area's higher cost of living and is generally comparable to NYC suburb pricing. Package deals for 6 sessions typically run $2,400–$3,000. Most clinics accept HSA and FSA payments.
Getting There & Logistics
Jersey City is highly accessible from Manhattan and the broader metro area via the PATH train, NJ Transit buses, and the NY Waterway ferry. Patients driving from New Jersey or outer-borough NYC will find parking easier and less expensive than in Manhattan. Patients should arrange a same-day escort after infusion sessions, as driving is not permitted following treatment. Many providers offer telehealth consultations for initial screenings, reducing the number of required in-person visits.